Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 18, 2025
Kalaris Announces Closing of Merger with AlloVir
GlobeNewswire
·
March 18, 2025
Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative diseases of the retina Currently enrolling nAMD patients in …
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
GlobeNewswire
·
March 18, 2025
Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA Obagi Medical …
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 18, 2025
SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth …
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
GlobeNewswire
·
March 18, 2025
IRVINE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that it will report fourth quarter 2024 financial results after the market closes on Monday, March 24, 2025. …
IR-MED CEO Issues Letter to Shareholders: Expanding Our Platform and Presenting New Clinical Data from Israel and the U.S.
GlobeNewswire
·
March 18, 2025
Rosh Pina, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- IR-MED Inc. (“IR-MED” or the “Company”) (OTCQB: IRME), a developer of noninvasive, AI-driven spectrographic analysis technology addressing significant healthcare needs, is pleased to share the following …
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 18, 2025
SAN MATEO, Calif., and CAMBRIDGE, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a biopharmaceutical company, today reported fourth quarter and full year 2024 financial results. Fourth Quarter and Full Year 2024 Financial …
Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
GlobeNewswire
·
March 18, 2025
RADNOR, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …
Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
GlobeNewswire
·
March 18, 2025
Pivotal Phase 3 OPERA-01 trial of palazestrant as a monotherapy in patients with 2/3L metastatic breast cancer on track for top-line data in 2026 Pivotal Phase 3 OPERA-02 trial of palazestrant in combination with ribociclib in patients with frontline …
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results
GlobeNewswire
·
March 18, 2025
Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24. Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an …
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 18, 2025
SOUTH SAN FRANCISCO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 14, 2025 it granted stock options to purchase an aggregate of 58,631 shares of common stock, 38,068 restricted stock …
National Fitness Partners Raises a Staggering $32,190 for the American Heart Association
GlobeNewswire
·
March 18, 2025
CAMP HILL, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- National Fitness Partners (NFP), a leading Planet Fitness franchise division, today announced that their month-long campaign to benefit the American Heart Association raised $32,190.04 to help fight heart …
BioAegis Therapeutics to Highlight Lead Product Gelsolin’s Critical Role in Immune Function at Upcoming Conferences
GlobeNewswire
·
March 18, 2025
Phase 2 clinical trial will be presented at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels, Belgium on March 19, 2025. COO Valerie Ceva will present at MedInvest Biotech …
Antibe Announces Completion of Sale
GlobeNewswire
·
March 18, 2025
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- Antibe Therapeutics Inc. (“Antibe” or the “Company”) announced that, in connection with its previously announced receivership proceedings, the Company completed a transaction (the “Transaction”) on March 17, 2025 …
Fabhalta Shakes Up the PNH Market in 15 Months as Soliris, Ultomiris, and Empaveli Compete and Voydeya and PiaSky Carve Their Niche
GlobeNewswire
·
March 18, 2025
EXTON, PA, March 18, 2025 (GLOBE NEWSWIRE) -- Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and debilitating blood disorder that affects approximately 8,000 to 10,000 people in North America and Western Europe.1 Patients often suffer from severe …
Compass Health Welcomes New Chief Financial Officer, Bringing More Than 20 Years of Experience to Advance Behavioral Healthcare in Northwest Washington
GlobeNewswire
·
March 18, 2025
EVERETT, Wash., March 18, 2025 (GLOBE NEWSWIRE) -- Compass Health, Northwest Washington’s behavioral healthcare leader, recently welcomed Janet Carbary as its new chief financial officer (CFO). With more than 20 years of experience in finance, healthcare …
Medical Devices Industry to Surpass $1.3 Trillion by 2029
GlobeNewswire
·
March 18, 2025
Boston, March 18, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Medical Devices Industry: Competitive Landscape” is projected to increase from 810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual …
Lipozem Reviews Consumer Reports Case Study Revealed, Trustworthy Reviews and Complaints, Cover All of its Aspects
GlobeNewswire
·
March 18, 2025
LAKELAND, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Lipozem is the result of nearly 20 years of research in metabolism, endocrinology, and holistic health by Dr. Julian Ross. Anyone who wants a natural metabolic boost and has been gaining weight over time …
The Joint Commission Announces Inaugural UNIFY 2025: Convening for Quality to Advance Patient Safety and Healthcare Quality
GlobeNewswire
·
March 18, 2025
OAKBROOK TERRACE, Illinois, March 18, 2025 (GLOBE NEWSWIRE) -- The Joint Commission today announced the inaugural UNIFY 2025: Convening for Quality, Sept. 16-17, 2025, in Washington, D.C. This groundbreaking event will gather healthcare leaders and …
MATTER 360 Diverts 7.1 Million Pounds of Medical Surplus from Landfills in 2024
GlobeNewswire
·
March 18, 2025
MINNEAPOLIS, March 18, 2025 (GLOBE NEWSWIRE) -- Minnesota-based global NGO MATTER announced today that its MATTER 360 initiative successfully diverted more than 7.1 million pounds of medical surplus from landfills in 2024, marking an increase from 6.5 …
TrainHealth Announces FDA Clearance of TrainFES Advanced, Improving Results in Neurological Rehabilitation
GlobeNewswire
·
March 18, 2025
PALO ALTO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- TrainHealth (www.trainhealth.ai), a commercial-stage neurological rehabilitation company, seeks to disrupt the neurological rehabilitation market with its new "TrainFES Advanced" device, which today …